These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results Terminated 2004-002249-11 Double blind, randomized, multicenter, placebo-controlled, parallel-group design clinical trial of the efficacy and tolerability of cloriclomene hydrochloride capsules 100 mg TID in diabetic patients ... bad-data
Not reported 2005-001589-15 A multi-center study evaluating the safety of a replacement intravitreal fluocinolone acetonide (FA) (0.59 mg) implant in patients with non-infectious posterior uveitis who were previously treated wit... 2006-01-13 due-trials
Ongoing 2006-000991-34 A randomized, double-blind, monocentric phase IV clinical study on the ocular tolerability of a topical ophthalmic product containing Retinolpalmitat 1000 I.U. in comparison to a reference product con... not-yet-due
Reported results 2007-001680-30 Randomized parallel-group, multicentre study to evaluate the after-use sensation and safety of carteolol LA 2% versus timolol LA 0.5% in simple intra-ocular hypertension and glaucoma. 2009-11-17 due-trials
Reported results 2007-004686-18 A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1 % Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After C... 2009-07-27 due-trials
Not reported Terminated 2007-005621-30 A multicenter, Investigator - masked, parallel-group, randomized study of the efficacy and safety of loteprednol etabonate 0.5% eyedrops versus dexamethasone 0.1% eyedrops in the treatment of ocular i... 2009-04-08 due-trials
Completed, but no date, and reported results 2007-005882-37 RANDOMIZED CONTROLLED CLINICAL STUDY ON THE EFFICACY AND TOLERABILITY OF 0.4% HYALURONIC ACID HYPOTONIC EYE DROPS (IALUREX) VS. HYDROXYPROPYL-GUAR EYE DROPS (SYSTANE) IN THE TREATMENT OF DRY EYE SYNDR... bad-data
Completed, but no date, and reported results Terminated 2009-011913-26 A Randomized, Multicenter, Double-Masked, Parallel-Group Dose Ranging Clinical Safety and Efficacy Evaluation of BOL-303242-X Ophthalmic Suspension versus Vehicle for the Treatment of Inflammation Fol... bad-data
Reported results 2010-018441-61 A Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Multicenter, Exploratory Study Assessing Safety and Efficacy of BOL-303242-X 2011-06-10 due-trials
Reported results 2010-019246-11 A Randomized, Multicenter, Double-Blind, Parallel-Group Clinical Safety and Efficacy Evaluation of Loteprednol Etabonate Ophthalmic Gel, 0.5% versus Vehicle for the Treatment of Inflammation and Pain ... 2010-08-25 due-trials
Reported results 2010-022178-14 A Randomized, Multicenter, Single-Masked, Parallel-Group Dose Finding Study Comparing the Safety and Efficacy of BOL-303259-X (0.006%, 0.012%, 0.024% and 0.040%) to Latanoprost 0.005% in Subjects with... 2011-12-20 due-trials
Reported results 2013-000552-18 A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic Solut... 2015-06-02 due-trials
Reported results 2013-000553-45 A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic Solut... 2014-11-26 due-trials

Related organisations

Over time organisations can merge, or split.

We think Bausch & Lomb Incorporated is now effectively part of Bausch Health.